Latest News - GlaxoSmithKline
Top Corporates Hub
GlaxoSmithKline
GSK
|
LSE
|
United Kingdom
268
-58
Rank
$77.93B
Market Cap
$40.18B
+$ 2.32B
+6.13%
Revenue
$0.00B
Earnings
68.6K
-1.6K
-2.25%
Employees
Akero: FGF21 Advancement For MASH Targeting Presses On With Key Developments
21.05.2025 15:25
Akero Therapeutics' efruxifermin shows strong potential in MASH, especially compensated cirrhosis. Click here to find out why AKRO stock is a Strong Buy.